Cargando…

Effect of 4-Week Consumption of Soy Kori-tofu on Cardiometabolic Health Markers: A Double-Blind Randomized Controlled Cross-Over Trial in Adults with Mildly Elevated Cholesterol Levels

Kori-tofu is a frozen soy tofu, and soy consumption is associated with positive effects on cardiometabolic health markers. We aimed to assess the potential of Kori-tofu to improve cardiometabolic health outcomes in humans by repetitive daily consumption. In a double-blind randomized controlled cross...

Descripción completa

Detalles Bibliográficos
Autores principales: van den Belt, Maartje, van der Haar, Sandra, Oosterink, Els, van Loenhout, Tom, Ishiguro, Takahiro, Esser, Diederik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9824620/
https://www.ncbi.nlm.nih.gov/pubmed/36615709
http://dx.doi.org/10.3390/nu15010049
_version_ 1784866454897688576
author van den Belt, Maartje
van der Haar, Sandra
Oosterink, Els
van Loenhout, Tom
Ishiguro, Takahiro
Esser, Diederik
author_facet van den Belt, Maartje
van der Haar, Sandra
Oosterink, Els
van Loenhout, Tom
Ishiguro, Takahiro
Esser, Diederik
author_sort van den Belt, Maartje
collection PubMed
description Kori-tofu is a frozen soy tofu, and soy consumption is associated with positive effects on cardiometabolic health markers. We aimed to assess the potential of Kori-tofu to improve cardiometabolic health outcomes in humans by repetitive daily consumption. In a double-blind randomized controlled cross-over trial, 45 subjects aged 40–70 years with (mildly) elevated cholesterol levels, received a four week Kori-tofu intervention or whey protein control intervention with a four week wash-out period in between. Cardiometabolic biomarkers were measured before and after both interventions. A significant decrease in total, low-density lipids (LDL), and high-density lipids (HDL) cholesterol, Hemoglobin A1c (HbA1c), fructosamine and systolic blood pressure was observed within the Kori-tofu intervention. However, many of these findings were also observed in the control intervention. Only adiponectin changes were different between treatments but did not change significantly within interventions. Improvements in cardiometabolic markers within the Kori-tofu intervention point toward potential beneficial health effects. Due to the lack of significant effects as compared to control, there is, however, currently no substantiating evidence to claim that Kori-tofu has beneficial effects on cardiometabolic health.
format Online
Article
Text
id pubmed-9824620
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98246202023-01-08 Effect of 4-Week Consumption of Soy Kori-tofu on Cardiometabolic Health Markers: A Double-Blind Randomized Controlled Cross-Over Trial in Adults with Mildly Elevated Cholesterol Levels van den Belt, Maartje van der Haar, Sandra Oosterink, Els van Loenhout, Tom Ishiguro, Takahiro Esser, Diederik Nutrients Article Kori-tofu is a frozen soy tofu, and soy consumption is associated with positive effects on cardiometabolic health markers. We aimed to assess the potential of Kori-tofu to improve cardiometabolic health outcomes in humans by repetitive daily consumption. In a double-blind randomized controlled cross-over trial, 45 subjects aged 40–70 years with (mildly) elevated cholesterol levels, received a four week Kori-tofu intervention or whey protein control intervention with a four week wash-out period in between. Cardiometabolic biomarkers were measured before and after both interventions. A significant decrease in total, low-density lipids (LDL), and high-density lipids (HDL) cholesterol, Hemoglobin A1c (HbA1c), fructosamine and systolic blood pressure was observed within the Kori-tofu intervention. However, many of these findings were also observed in the control intervention. Only adiponectin changes were different between treatments but did not change significantly within interventions. Improvements in cardiometabolic markers within the Kori-tofu intervention point toward potential beneficial health effects. Due to the lack of significant effects as compared to control, there is, however, currently no substantiating evidence to claim that Kori-tofu has beneficial effects on cardiometabolic health. MDPI 2022-12-22 /pmc/articles/PMC9824620/ /pubmed/36615709 http://dx.doi.org/10.3390/nu15010049 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
van den Belt, Maartje
van der Haar, Sandra
Oosterink, Els
van Loenhout, Tom
Ishiguro, Takahiro
Esser, Diederik
Effect of 4-Week Consumption of Soy Kori-tofu on Cardiometabolic Health Markers: A Double-Blind Randomized Controlled Cross-Over Trial in Adults with Mildly Elevated Cholesterol Levels
title Effect of 4-Week Consumption of Soy Kori-tofu on Cardiometabolic Health Markers: A Double-Blind Randomized Controlled Cross-Over Trial in Adults with Mildly Elevated Cholesterol Levels
title_full Effect of 4-Week Consumption of Soy Kori-tofu on Cardiometabolic Health Markers: A Double-Blind Randomized Controlled Cross-Over Trial in Adults with Mildly Elevated Cholesterol Levels
title_fullStr Effect of 4-Week Consumption of Soy Kori-tofu on Cardiometabolic Health Markers: A Double-Blind Randomized Controlled Cross-Over Trial in Adults with Mildly Elevated Cholesterol Levels
title_full_unstemmed Effect of 4-Week Consumption of Soy Kori-tofu on Cardiometabolic Health Markers: A Double-Blind Randomized Controlled Cross-Over Trial in Adults with Mildly Elevated Cholesterol Levels
title_short Effect of 4-Week Consumption of Soy Kori-tofu on Cardiometabolic Health Markers: A Double-Blind Randomized Controlled Cross-Over Trial in Adults with Mildly Elevated Cholesterol Levels
title_sort effect of 4-week consumption of soy kori-tofu on cardiometabolic health markers: a double-blind randomized controlled cross-over trial in adults with mildly elevated cholesterol levels
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9824620/
https://www.ncbi.nlm.nih.gov/pubmed/36615709
http://dx.doi.org/10.3390/nu15010049
work_keys_str_mv AT vandenbeltmaartje effectof4weekconsumptionofsoykoritofuoncardiometabolichealthmarkersadoubleblindrandomizedcontrolledcrossovertrialinadultswithmildlyelevatedcholesterollevels
AT vanderhaarsandra effectof4weekconsumptionofsoykoritofuoncardiometabolichealthmarkersadoubleblindrandomizedcontrolledcrossovertrialinadultswithmildlyelevatedcholesterollevels
AT oosterinkels effectof4weekconsumptionofsoykoritofuoncardiometabolichealthmarkersadoubleblindrandomizedcontrolledcrossovertrialinadultswithmildlyelevatedcholesterollevels
AT vanloenhouttom effectof4weekconsumptionofsoykoritofuoncardiometabolichealthmarkersadoubleblindrandomizedcontrolledcrossovertrialinadultswithmildlyelevatedcholesterollevels
AT ishigurotakahiro effectof4weekconsumptionofsoykoritofuoncardiometabolichealthmarkersadoubleblindrandomizedcontrolledcrossovertrialinadultswithmildlyelevatedcholesterollevels
AT esserdiederik effectof4weekconsumptionofsoykoritofuoncardiometabolichealthmarkersadoubleblindrandomizedcontrolledcrossovertrialinadultswithmildlyelevatedcholesterollevels